Video

Q&A With Fred Poordad From the Texas Liver Institute: Ally 1 Study Looks at Treatments for Patients with Liver Transplant

Author(s):

For patients who have undergone a liver transplant or have severe liver disease finding the right medications can be critical in their overall care.

For patients who have undergone a liver transplant or have severe liver disease finding the right medications can be critical in their overall care.

Fred Poordad, MD, from the Texas Liver Institute discussed the results of the study at the 2015 International Liver Congress in Vienna.

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Allysa Saggese, NP | Credit: Weill Cornell Medicine
Zobair Younossi, MD, MPH | Credit: American College of Gastroenterology
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
© 2024 MJH Life Sciences

All rights reserved.